We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.3%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGP icon
1426
EastGroup Properties
EGP
$10.9B
$65K ﹤0.01%
562
+532
+1,773% +$60.2K
ICUI icon
1427
ICU Medical
ICUI
$4.56B
$65K ﹤0.01%
258
-374
-59% -$86.7K
IWB icon
1428
iShares Russell 1000 ETF
IWB
$50.2B
$65K ﹤0.01%
400
+399
+39,900% +$63.9K
KHC icon
1429
Kraft Heinz
KHC
$29.6B
$65K ﹤0.01%
2,079
-16,177
-89% -$510K
LRN icon
1430
Stride
LRN
$3.33B
$65K ﹤0.01%
2,140
+775
+57% +$24.9K
OVV icon
1431
Ovintiv
OVV
$17.6B
$65K ﹤0.01%
2,548
+2,212
+658% +$69K
SR icon
1432
Spire
SR
$4.79B
$65K ﹤0.01%
776
-37
-5% -$3.1K
STNE icon
1433
StoneCo
STNE
$2.52B
$65K ﹤0.01%
2,214
+1,156
+109% +$34K
SVC
1434
Service Properties Trust
SVC
$1.05B
$65K ﹤0.01%
514
-1,985
-79% -$255K
ZTO icon
1435
ZTO Express
ZTO
$18.2B
$65K ﹤0.01%
+3,396
New +$63.9K
VSA
1436
VisionSys AI
VSA
$9.38M
$65K ﹤0.01%
10
-3
-23% -$30.7K
BCPC
1437
Balchem Corp
BCPC
$5.65B
$65K ﹤0.01%
+651
New +$63.3K
GOL
1438
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$65K ﹤0.01%
3,867
-14,547
-79% -$193K
MNDT
1439
DELISTED
Mandiant, Inc. Common Stock
MNDT
$65K ﹤0.01%
4,364
+201
+5% +$3.08K
AVX
1440
DELISTED
AVX Corporation
AVX
$65K ﹤0.01%
+3,941
New +$64.9K
BHVN
1441
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$65K ﹤0.01%
+1,476
New +$83.2K
ABCB icon
1442
Ameris Bancorp
ABCB
$5.88B
$64K ﹤0.01%
1,621
+658
+68% +$24K
ATI icon
1443
ATI
ATI
$31.1B
$64K ﹤0.01%
+2,544
New +$62K
BHF icon
1444
Brighthouse Financial
BHF
$3.46B
$64K ﹤0.01%
1,753
-3,118
-64% -$120K
BRFS
1445
DELISTED
BRF SA
BRFS
$64K ﹤0.01%
8,370
+5,625
+205% +$40.7K
CNK icon
1446
Cinemark Holdings
CNK
$4.38B
$64K ﹤0.01%
1,772
-5,197
-75% -$205K
SF
1447
Stifel
SF
$12.7B
$64K ﹤0.01%
2,435
+2,401
+7,062% +$61.1K
SLM icon
1448
SLM Corp
SLM
$5.14B
$64K ﹤0.01%
6,665
-4,831
-42% -$47.9K
SM icon
1449
SM Energy
SM
$7.55B
$64K ﹤0.01%
5,119
-2,651
-34% -$38.5K
DCPH
1450
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$64K ﹤0.01%
+2,863
New +$67K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.